These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20065629)

  • 1. Letter from the editor.
    Reichert JM
    MAbs; 2009; 1(3):189. PubMed ID: 20065629
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibody-Based Drugs and Other Recombinant Proteins for Diagnostics and Therapy of Viral Infections, Autoimmune Diseases and Cancer].
    Kuprash DV; Garib FY; Nedospasov SA
    Mol Biol (Mosk); 2017; 51(6):883-885. PubMed ID: 29271953
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic antibodies and antibody fusion proteins.
    Rohrbach P; Broders O; Toleikis L; Dübel S
    Biotechnol Genet Eng Rev; 2003; 20():137-63. PubMed ID: 14997850
    [No Abstract]   [Full Text] [Related]  

  • 4. Promising drug is victim of bad business.
    Dove A
    Nat Med; 2002 Mar; 8(3):199. PubMed ID: 11875472
    [No Abstract]   [Full Text] [Related]  

  • 5. bioLOGIC Europe 2007--Terrapinn's eighth annual conference.
    Mackay J
    IDrugs; 2007 Aug; 10(8):543-8. PubMed ID: 17665328
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic applications of monoclonal antibodies.
    Berger M; Shankar V; Vafai A
    Am J Med Sci; 2002 Jul; 324(1):14-30. PubMed ID: 12120821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic antibodies: magic bullets hit the target.
    Gura T
    Nature; 2002 Jun; 417(6889):584-6. PubMed ID: 12050630
    [No Abstract]   [Full Text] [Related]  

  • 8. New discoveries still abundant in monoclonal antibody research.
    Garber K
    J Natl Cancer Inst; 2000 Sep; 92(18):1462-4. PubMed ID: 10995796
    [No Abstract]   [Full Text] [Related]  

  • 9. Engineering antibodies for the clinic.
    Holliger P; Bohlen H
    Cancer Metastasis Rev; 1999; 18(4):411-9. PubMed ID: 10855784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antibody which behaves like a man with a wife and a mistress.
    Griffiths PD
    Rev Med Virol; 2009 Jul; 19(4):181-3. PubMed ID: 19530116
    [No Abstract]   [Full Text] [Related]  

  • 11. Engineering mouse monoclonal antibodies for cancer immunotherapy.
    Orlandi R
    Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody-targeted RNase fusion proteins (immunoRNases) for cancer therapy.
    Krauss J; Arndt MA; Dübel S; Rybak SM
    Curr Pharm Biotechnol; 2008 Jun; 9(3):231-4. PubMed ID: 18673289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guardians at the gate: Biosimilar and patent reform legislation could fundamentally change the guards for therapeutic monoclonal antibodies--Part 2.
    McCabe KW
    MAbs; 2009; 1(5):417-21. PubMed ID: 20065635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Engineering Antibodies as Drugs: Principles and Practice].
    Lugovskoy AA
    Mol Biol (Mosk); 2017; 51(6):886-898. PubMed ID: 29271954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First biotech drug to treat psoriasis.
    Mitchell P
    Nat Biotechnol; 2002 Jul; 20(7):640-1. PubMed ID: 12089534
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent patent applications related to antibodies.
    Nat Biotechnol; 2005 Sep; 23(9):1081. PubMed ID: 16151396
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of antibodies and chimeric molecules for cancer immunotherapy.
    Waldmann TA; Morris JC
    Adv Immunol; 2006; 90():83-131. PubMed ID: 16730262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1(st) French-Israeli International Conference on B Cells and therapeutic antibodies: October 23-25, 2011 Jerusalem, Israel.
    Reynaud CA; Moutel S; Dieu-Nosjean MC; Laskov R; Teillaud JL
    MAbs; 2012; 4(4):426-33. PubMed ID: 22664457
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter from the Editor: stratified medicine.
    Reichert JM
    MAbs; 2010; 2(2):107. PubMed ID: 21358857
    [No Abstract]   [Full Text] [Related]  

  • 20. The value and effectiveness of angiogenesis inhibitors for colorectal cancer.
    Venook AP
    Clin Adv Hematol Oncol; 2015 Sep; 13(9):561-3. PubMed ID: 26452184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.